The cyclin D1 gene is transcriptionally repressed by caveolin-1

J Hulit1, T Bash, M Fu

  • 1Albert Einstein Cancer Center, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Insights

Caveolin-1 negatively regulates cyclin D1 gene expression, impacting cellular transformation. This finding suggests caveolin-1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Cyclin D1 is a key regulator of cell cycle progression, often dysregulated in cancer.
  • Caveolins are involved in signal transduction and membrane dynamics.
  • Previous studies link cyclin D1 to cellular transformation via oncogenic signaling pathways.

Purpose of the Study:

  • To investigate the relationship between caveolin-1 and cyclin D1 expression.
  • To determine the mechanism by which caveolin-1 affects cyclin D1 gene regulation.
  • To explore the role of this interaction in cellular transformation.

Main Methods:

  • Analysis of cyclin D1 and caveolin-1 expression levels in transformed cells.
  • Manipulation of caveolin-1 expression using antisense and overexpression techniques.
  • Reporter gene assays to assess cyclin D1 promoter activity.
  • Site-directed mutagenesis of the cyclin D1 promoter.

Main Results:

  • Caveolin-1 expression inversely correlates with cyclin D1 levels in transformed cells.
  • Caveolin-1 overexpression represses cyclin D1 gene expression and promoter activity.
  • Repression is mediated through the T-cell factor/lymphoid enhancer-1 binding site on the cyclin D1 promoter.
  • The N-terminus of caveolin-1 is crucial for this repression.

Conclusions:

  • Caveolin-1 acts as a transcriptional repressor of the cyclin D1 gene.
  • This repression mechanism may contribute to caveolin-1's tumor-suppressive effects.
  • Understanding this pathway offers potential therapeutic targets for cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...